Apollo Hospitals Enterprise Limited has received the formal court order regarding its proposed composite scheme of arrangement. The order, issued by the National Company Law Tribunal, confirms updated schedules for convening meetings of equity shareholders and creditors. These meetings are critical milestones for the restructuring involving Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited, ensuring the transition proceeds according to the revised timeline set for May 2026.
Tribunal Order and Meeting Rescheduling
Apollo Hospitals has officially received the certified true copy of the order passed by the National Company Law Tribunal in Chennai. The order facilitates the necessary adjustments to the timelines for the proposed composite scheme of arrangement, which involves several internal entities, including Apollo Healthco Limited, Keimed Private Limited, and Apollo Healthtech Limited.
Updated Meeting Schedule
As per the tribunal’s direction, the company has updated the schedule for its upcoming stakeholder meetings to ensure compliance and proper conduct. The key dates are as follows:
- Secured Creditors of Applicant Company 1: Meeting scheduled for May 27, 2026, at 10:00 AM.
- Equity Shareholders of Applicant Company 1: Meeting rescheduled to May 27, 2026, at 02:30 PM.
- Unsecured Creditors of Applicant Company 1: Meeting rescheduled to May 27, 2026, at 11:00 AM.
- Unsecured Creditors of Applicant Company 2: Meeting date moved to May 26, 2026, at 10:00 AM.
- Unsecured Creditors of Applicant Company 3: Meeting date moved to May 26, 2026, at 03:00 PM.
Procedural Developments
In addition to rescheduling, the tribunal has approved the venue for the meeting of Unsecured Creditors of Applicant Company 3, which will now take place at Palepu Pharma Distributors Private Limited, located in Kottivakkam, Chennai. The company remains committed to finalizing these arrangements and moving forward with the scheme, which seeks to reorganize its business operations for enhanced efficiency and growth.
Source: BSE
